Please login to the form below
New data from Moderna supports COVID boosters
Waning immunity from its mRNA jab “support benefit” of a booster shot, says Moderna, while international scientists publish plea for evidence over politics
$47.5m research centre to seek genetic insights into disease
The Novo Nordisk Foundation and Broad Institute have teamed up to mine genetic data for disease insights and help develop the next generation of researchers
UK announces COVID boosters for a “bumpy winter” ahead
A single shot of Pfizer’s COVID-19 vaccine will be offered to 30 million people in the UK including those 50 or over and frontline health and social care workers
Embattled Biogen talks up Aduhelm
Biogen CEO admitted the company was experiencing “near-term challenges” after the controversial approval of Alzheimer’s drug, Aduhelm
Future of MHRA uncertain amid Brexit-fuelled shake up
Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions
Tezepelumab effective in severe asthma with comorbid nasal polyps
Amgen’s novel drug offers hope to the one-in-five people with severe asthma who also have nasal polyps
FDA pauses BioMarin gene therapy trial
The study for BMN 307 in genetic disease phenylketonuria will be paused while malignancies in mice are explored
Pfizer starts RSV trial ahead of winter season
A vaccine against the common respiratory syncytial virus could be available soon, as Pfizer joins GSK and J&J in launching phase 3 trials
Congress “concerned by apparent anomalies” around FDA’s approval of Aduhelm
Congress demands more information from the FDA on its controversial approval of Biogen’s Alzheimer’s drug and its dealings with the company.
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
New data advances AstraZeneca’s “revolution in oncology”In a busy few weeks for AstraZeneca, the company will present data on 14 approved and potential drugs in lung and breast cancer
-
FDA experts to evaluate Pfizer-BioNTech COVID-19 boosterAs Moderna announces it has submitted COVID-19 vaccine booster data, the FDA advisory committee of outside experts will convene in two weeks’ time
-
UK’s NICE recommends anti-cholesterol Leqvio for high-risk patientsThe approval for the Novartis drug by the NHS gatekeeper could save 30,000 lives over 10 years
-
Merck’s anti-COVID drug molnupiravir moves to phase 3 for preventionThe MOVe-AHEAD trial will test whether the drug prevents infection in those living in the same household as someone with confirmed COVID-19
-
McCann Health, Dovetail, Evoke and Oxford PharmaGenesis among big winners at Communiqué AwardsSee the full list of the results from the Awards held at London’s Grosvenor House Hotel
-
Mixed results for AC Immune's promising Alzheimer’s antibodyShares in AC Immune rose more than 75% on the news that semorinemab met one of two study endpoints
-
GSK/SK bioscience COVID-19 vaccine to enter phase 3 trialThe study will be one of the first global phase 3 trials to compare two different COVID-19 vaccine candidates
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life SciencesCaulfield served as chief scientist at Genomics England, working on the 100,000 Genomes Project
-
AZ appoints Susan Galbraith as executive vice president, oncology R&DGalbraith’s appointment into the role follows the passing of José Baselga earlier this year
-
AZ appoints Alexion’s Aradhana Sarin as chief financial officerSarin will become AZ's new chief financial officer upon closing of the company’s acquisition of Alexion Pharmaceuticals
-
Doina Ionescu elected to ABPI’s board of directorsIonescu is managing director and general manager for Merck Healthcare UK and Ireland
-
CureVac taps Klaus Edvardsen for chief development officer roleEdvardsen joins the German biopharma company from Merck KGaA
Latest research appointments
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Embattled Biogen talks up Aduhelm
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- New data from Moderna supports COVID boosters
- $47.5m research centre to seek genetic insights into disease
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Nicky Hutchens appointed as deputy managing director at Four Health
- Health For All
- Digitalizing Muskuloskeletal Care to Improve Patient Outcomes and Reduce Cost
No results were found
PMHub
JPA Health
JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...
Latest intelligence
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
- How to pick the perfect training program for your healthcare professionals
- You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...
